| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| RHEINMETALL | 43 | 42 | -2,63 % | ||
| SANOFI | 32 | 42 | -0,13 % | ||
| UBS | 24 | 188 | +0,17 % | ||
| AIRBUS | 17 | 135 | +1,10 % | ||
| SIEMENS | 17 | 124 | +0,89 % | ||
| DEUTSCHE TELEKOM | 17 | 56 | -0,93 % | ||
| SAP | 15 | 41 | +0,70 % | ||
| HSBC | 10 | 139 | +0,94 % | ||
| NOVO NORDISK | 10 | 40 | -0,18 % | ||
| SHELL | 8 | 90 | -0,13 % |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 06:13 | Fluence Energy: Welche Aussichten hat das Siemens-Joint-Venture? | 4 | ECOreporter | ||
| 06:12 | UBS Group Chief Operations And Technology Officer Mike Dargan To Resign At December - End | 57 | AFX News | WASHINGTON (dpa-AFX) - Swiss banking major UBS Group AG (UBS) announced Monday that Mike Dargan, Group Chief Operations and Technology Officer, has decided to step down from his role at the... ► Artikel lesen | |
| 06:10 | Rheinmetall, Almonty Industries, Theon - Friedensgespräche eröffnen Chancen | 83 | inv3st.de | Die Hoffnung auf einen Waffenstillstand in der Ukraine bewegt derzeit nicht nur die Politik, sondern auch die Börsen. Während in Berlin auf höchster Ebene über einen möglichen Friedensplan verhandelt... ► Artikel lesen | |
| 05:59 | UBS Group Chief Operations And Technology Officer Mike Dargan To Resign At December - End | 5 | RTTNews | ||
| 05:46 | Novo Nordisk setzt Ausrufezeichen! TUI mit Kurssprung! Globex Aktie stark! | 320 | ESG-Aktien.de | Novo Nordisk kann das Horrorjahr 2025 mit einer positiven Meldung ausklingen lassen. Die EMA eine positive Stellungnahme für eine höhere Wegovy-Dosierung abgegeben. Der Verkaufsstart könnte schon im... ► Artikel lesen | |
| 05:22 | Adel Signs Alzheimer's Drug Licensing Deal With Sanofi Worth Up to 1.53 Tril. Won | 3 | BusinessKorea | ||
| 04:48 | AstraZeneca: ENHERTU Combination Approved In US For 1st-Line HER2-Positive Metastatic Breast Cancer | 209 | AFX News | LONDON (dpa-AFX) - AstraZeneca and Daiichi Sankyo's ENHERTU (fam-trastuzumab deruxtecan-nxki), in combination with pertuzumab, has received approval in the United States for the first-line treatment... ► Artikel lesen | |
| 00:37 | Airbus CEO Sees Boeing Regaining Lead in 2025 Aircraft Orders | 4 | Mexico Business News | ||
| Mo | AstraZeneca, Daiichi score with FDA nod for Enhertu combo in 1st-line breast cancer | 4 | FiercePharma | ||
| Mo | Breaking: UBS Tech Head to Exit - Incoming COO Takes Control | 3 | finews.asia | ||
| Mo | AstraZeneca's Enhertu and Genentech's Perjeta combo gains breast cancer approval | 3 | Seeking Alpha | ||
| Mo | Rio Tinto: Rhodes Ridge Joint Venture partners begin $191 million feasibility study on up to 50Mtpa Pilbara iron ore mine | 210 | Business Wire | The Rhodes Ridge Joint Venture has approved a $191 million (A$294 million) (Rio Tinto share $96 million, A$147 million) feasibility study to progress development of the first phase of the Rhodes Ridge... ► Artikel lesen | |
| Mo | Banco Santander S.A. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| Mo | Novo's oral semaglutide edges out CagriSema, Lilly's orforglipron as PCPs' most-anticipated obesity med | 43 | FiercePharma | ||
| Mo | Ookla: T-Mobile Is Fastest Fixed Wireless Access Provider | 24 | tvtech | ||
| Mo | Moody's stuft Einlagenratings der BBVA auf A1 hoch; Ausblick stabil | 3 | Investing.com Deutsch | ||
| Mo | AstraZeneca and Daiichi Sankyo's enhertu gets US cancer approval | 2 | Alliance News | ||
| Mo | GSK receives UK marketing approval for asthma treatment Exdensur | 3 | Alliance News | ||
| Mo | Loro Piana opens new boutique at Cortina d'Ampezzo in Italy | 5 | CPP LUXURY | ||
| Mo | Roche erhält FDA-Zulassung für zwei Diagnosetests im Bereich Brustkrebs | 8 | cash |